Search results

...be considered a drug. This list categorises drugs alphabetically and also by other categorisations. <!-- Do contribute by editing or expanding the list. Refer to talk page for contributor notes on ...

{{Short description|Category of drugs used to classify a drug according to certain criteria}} ...set of [[medication]]s and other compounds that have a similar [[chemical structure]]s, the same [[mechanism of action]] (i.e. binding to the same [[biological ...

{{Short description|Category of drugs used to classify a drug according to certain criteria}} ...set of [[medication]]s and other compounds that have a similar [[chemical structure]]s, the same [[mechanism of action]] (i.e. binding to the same [[biological ...

薬物クラス（'''drug class'''）とは、類似した[[chemical structure/ja|化学構造]]を持ち、同じ[[mechanism of action/ja|作用機序(mechanism of action)]]（すなわち、同じ 薬物クラス一覧: [https://www.drugs.com/drug-classes.html] ...

...by [[ClinicalTrials.gov]] registry to classify which diseases are studied by trials registered in ClinicalTrials. ==Structure== ...

...by [[ClinicalTrials.gov]] registry to classify which diseases are studied by trials registered in ClinicalTrials. ==Structure== <!--T:3--> ...

...hyl]]. These are broad-spectrum herbicides that kill plants weeds or pests by inhibiting the enzyme [[acetolactate synthase]]. In the 1960s, more than {{ ...abetic drug]]s in the management of [[diabetes mellitus type 2]]. They act by increasing [[secretion]] of [[insulin]] from the [[beta cell]]s in the [[pa ...

|ImageFile = Ergosterol structure.svg ...tage could be linked to the presence of two conjugated double bonds in the structure (B-ring) of ergosterol giving it antioxidant properties. ...

|ImageFile = Ergosterol structure.svg ...tage could be linked to the presence of two conjugated double bonds in the structure (B-ring) of ergosterol giving it antioxidant properties. ...

...hyl]]. These are broad-spectrum herbicides that kill plants weeds or pests by inhibiting the enzyme [[acetolactate synthase]]. In the 1960s, more than {{ ...abetic drug]]s in the management of [[diabetes mellitus type 2]]. They act by increasing [[secretion]] of [[insulin]] from the [[beta cell]]s in the [[pa ...

...g Statistics Methodology |access-date=6 July 2021}}</ref> It is controlled by the [[World Health Organization]] Collaborating Centre for Drug Statistics This [[Pharmaceutical code|pharmaceutical coding system]] divides drugs into different groups according to the organ or system on which they act, t ...

...It does ''not'' include any [[breastfeeding#Medication use|risks conferred by pharmaceutical agents or their metabolites in breast milk]]. ...literature. The [[British National Formulary]] used to provide a table of drugs to be avoided or used with caution in pregnancy, and did so using a limited ...

...[NADPH]] are derivatives of 1,4-dihydropyridine. 1,4-Dihydropyridine-based drugs are [[L-type calcium channel|<small>L</small>-type calcium channel]] blocke [[File:HantzschEster.svg|thumb|left|Chemical structure of Hantzsch's ethyl ester, a well-known dihydropyridine.]] ...

{{Short description|Group of antihypertensive drugs}} ...nsin II]] (Ang II) in the body, thereby lowering [[blood pressure]]. Their structure is similar to Ang II and they bind to [[Angiotensin receptor|Ang II recepto ...

| caption = Chemical structure of [[ethyl eicosapentaenoate]], an important omega-3-acid ethyl ester | Drugs.com = {{drugs.com|monograph|omega-3-acid-ethyl-esters}} ...

...renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[glucosuria]]. The mechanism of action is insulin independent. ...liflozin]]. Canagliflozin was the first SGLT-2 inhibitor that was approved by the FDA, being accepted in March 2013. Dapagliflozin and empagliflozin were ...

{{Short description|Group of antihypertensive drugs}} ...nsin II]] (Ang II) in the body, thereby lowering [[blood pressure]]. Their structure is similar to Ang II and they bind to [[Angiotensin receptor|Ang II recepto ...

| caption = Chemical structure of [[ethyl eicosapentaenoate]], an important omega-3-acid ethyl ester | Drugs.com = {{drugs.com|monograph|omega-3-acid-ethyl-esters}} ...

...renal excretion and prevents [[glucose]] from going into blood circulation by promoting [[glucosuria]]. The mechanism of action is insulin independent. ...liflozin]]. Canagliflozin was the first SGLT-2 inhibitor that was approved by the FDA, being accepted in March 2013. Dapagliflozin and empagliflozin were ...

{{Short description|Online database containing information on drugs and drug targets}} | scope = Chemical structures, small molecule drugs, biotech drugs, drug targets, drug transporters, drug target sequences, drug target SNPs, ...